Genetic Registry for Rheumatoid Arthritis
NCT00069472 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1062
Last updated 2015-09-10
Summary
Many genes are thought to contribute to rheumatoid arthritis (RA). This study will attempt to identify genes that may contribute to RA.
Conditions
Sponsors & Collaborators
-
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
collaborator NIH -
Arthritis Foundation
collaborator OTHER -
Northwell Health
lead OTHER
Principal Investigators
-
Peter K. Gregersen, MD · North Shore University Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2002-10-31
- Primary Completion
- 2015-08-31
- Completion
- 2015-08-31
Countries
- United States
Study Locations
More Related Trials
-
Identification of Genomic Biomarkers for Rheumatoid Arthritis With Late Onset
NCT05808309 ·Status: WITHDRAWN
-
Prediction of Methotrexate Response - A Pilot Study
NCT01726959 ·Status: COMPLETED
-
Prospective, Multi-Center, Observational, Whole Blood Specimen Collection Study in Participants with Rheumatoid Arthritis with Inadequate Response or Intolerance to a DMARD Starting a New BDMARD or TsDMARD Treatment +/- CsDMARD
NCT05936970 ·Status: RECRUITING
-
Network to Understand Reproductive Rheumatology Registry
NCT06940869 ·Status: ENROLLING_BY_INVITATION
-
The Pathogenesis of Inflammatory Synovitis: A Study of Early Arthritis
NCT00001375 ·Status: COMPLETED
-
Predicting the Response of Patients With Rheumatoid Arthritis to Treatment With Genetically Engineered Biological Drugs and Janus (JAK) Kinase Inhibitors
NCT06177405 ·Status: COMPLETED
-
Treatment of Early RA: Minocycline in Combination With Methotrexate vs Methotrexate Alone
NCT00579644 ·Status: COMPLETED ·Phase: PHASE3
-
Rheumatoid Arthritis Synovial Tissue Biopsy Study
NCT07000890 ·Status: COMPLETED ·Phase: NA
-
CorEvitas Rheumatoid Arthritis (RA) Drug Safety & Effectiveness Registry
NCT01402661 ·Status: ENROLLING_BY_INVITATION
-
Identification of Epigenetic Biomarkers for Early Detection of Rheumatic Disease
NCT02742337 ·Status: UNKNOWN
-
Characterize Patients With Moderately Active Rheumatoid Arthritis (RA)
NCT01557322 ·Status: COMPLETED
-
Juvenile Rheumatoid Arthritis Research Registry
NCT00090571 ·Status: COMPLETED
-
RORC Genetic Polymorphism of Rheumatoid Arthritis
NCT03615729 ·Status: COMPLETED
-
To Investigate Genetic Factors Associated With the Response to Anti-TNF Therapy in Patients With Early AS
NCT02311842 ·Status: COMPLETED
-
Study of Human Leukocyte Antigen (HLA) Polymorphisms in Patients With Rheumatoid Arthritis
NCT01111357 ·Status: COMPLETED
-
Microbial Dysbiosis in Rheumatoid Arthritis
NCT03802890 ·Status: UNKNOWN
-
Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response
NCT03414502 ·Status: RECRUITING ·Phase: PHASE3
-
Rheumatology Biorepository
NCT04899895 ·Status: ENROLLING_BY_INVITATION
-
Comparison of the Safety and Pharmacokinetics of Two SAR153191 (REGN88) Drug Products in Rheumatoid Arthritis Patients
NCT01328522 ·Status: COMPLETED ·Phase: PHASE1
-
Prognostic Indicators and Determinants of the 2-5 Year Outcome in a Cohort of Early Synovitis Patients
NCT00001679 ·Status: COMPLETED
-
Study of Families With Twins or Siblings Discordant for Rheumatic Disorders
NCT00055055 ·Status: COMPLETED
-
Survivin as Predictive Biomarker for RA
NCT03444623 ·Status: UNKNOWN
-
Switching Anti-TNF-Alpha Agents in Rheumatoid Arthritis (RA)
NCT00796705 ·Status: TERMINATED ·Phase: PHASE4
-
Ticagrelor in Methotrexate-Resistant Rheumatoid Arthritis
NCT02874092 ·Status: COMPLETED ·Phase: PHASE4
-
Safety Study of a Single Dose of REGN88(SAR153191)in Patients With Rheumatoid Arthritis
NCT01055899 ·Status: COMPLETED ·Phase: PHASE1